Ultra-Low Dose IL-2 Expands Natural Regulatory T Cells and CD56bright NK Cells in Patients and Healthy Donors and Is Associated with Clinical Improvement in Chronic Graft Versus Host Disease

Authors

Samantha A Miner DPM, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

2-2013

Volume

19

Issue

2

First Page

147

Last Page

148

Published In/Presented At

https://doi.org/10.1016/j.bbmt.2012.11.098

Disciplines

Medicine and Health Sciences

Department(s)

Fellows and Residents

Document Type

Article